Evidence

Science-backed. Trial-tested

Explore the growing body of evidence behind Jinkō, from peer-reviewed publications to in-depth case studies, white papers, and expert insights.

Featured: In Silico prospective predictions

Flaura2 / MariposaIn silico prospective simulations independently estimated PFS outcomes of the Phase III MARIPOSA trial in EGFR-mutated NSCLC, and modeled pemetrexed maintenance de-escalation strategies in the FLAURA2 regimen.

ASCVD / CORALreefA mechanistic QSP model of atherosclerosis prospectively predicted LDL-C outcomes of the Phase 3 CORALreef Lipids trial, building on prior validation of the SIRIUS in silico cardiovascular outcomes model.

Scientific evidence

Publications & posters

Peer-reviewed publications and scientific posters presented at international conferences, showcasing the clinical validation of Jinkō.

Explore

Applied research

Case studies & deep dives

Real-world applications of mechanistic modeling: how Jinkō shaped trial design decisions before the first patient enrolled, across multiple disease areas.

Explore

Technical insights

White papers

In-depth technical and strategic papers exploring how model-informed drug development transforms R&D productivity and regulatory confidence.

Explore

News & insights

Blog

Expert perspectives, platform updates, and commentary from the Nova In Silico team on clinical simulation and AI in drug development.

Explore

Want to see Jinkō in action?

Book a demo with our team and discover how mechanistic trial simulation can accelerate your next program.

Request a demo